|
1
|
Francis GS, Benedict C, Johnstone DE,
Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E and Yusuf
S: Comparison of neuroendocrine activation in patients with left
ventricular dysfunction with and without congestive heart failure.
A substudy of the studies of left ventricular dysfunction (SOLVD).
circulation. 82:1724–1729. 1990. View Article : Google Scholar
|
|
2
|
Zhang ZH, Francis J, Weiss RM and Felder
RB: The renin-angiotensin-aldosterone system excites hypothalamic
paraventricular nucleus neurons in heart failure. Am J Physiol
Heart Circ Physiol. 283:H423–H433. 2002. View Article : Google Scholar
|
|
3
|
Levine B, Kalman J, Mayer L, Fillit HM and
Packer M: Elevated circulating levels of tumor necrosis factor in
severe chronic heart failure. N Engl J Med. 323:236–241. 1990.
View Article : Google Scholar
|
|
4
|
Francis J, Chu Y, Johnson AK, Weiss RM and
Felder RB: Acute myocardial infarction induces hypothalamic
cytokine synthesis. Am J Physiol Heart Circ Physiol.
286:H2264–H2271. 2004. View Article : Google Scholar
|
|
5
|
Guggilam A, Haque M, Kerut EK, McIlwain E,
Lucchesi P, Seghal I and Francis J: TNF-alpha blockade decreases
oxidative stress in the paraventricular nucleus and attenuates
sympathoexcitation in heart failure rats. Am J Physiol Heart Circ
Physiol. 293:H599–H609. 2007. View Article : Google Scholar
|
|
6
|
Dawson VL and Dawson TM: Nitric oxide
neurotoxicity. J Chem Neuroanat. 10:179–190. 1996. View Article : Google Scholar
|
|
7
|
Liu Q, Wang T, Yu H, Liu B and Jia R:
Interaction between interleukin-1 beta and angiotensin II receptor
1 in hypothalamic paraventricular nucleus contributes to
progression of heart failure. J Interferon Cytokine Res.
34:870–875. 2014. View Article : Google Scholar :
|
|
8
|
Wei P, Yang XJ, Fu Q, Han B, Ling L, Bai
J, Zong B and Jiang CY: Intermedin attenuates myocardial infarction
through activation of autophagy in a rat model of ischemic heart
failure via both cAMP and MAPK/ERK1/2 pathways. Int J Clin Exp
Pathol. 8:9836–9844. 2015.
|
|
9
|
Duan HY, Liu DM, Qian P, Wang SL, Yan LJ,
Wu JT, Yang HT, Fan XW and Chu YJ: Effect of atorvastatin on plasma
NT-proBNP and inflammatory cytokine expression in patients with
heart failure. Genet Mol Res. 14:15739–15748. 2015. View Article : Google Scholar
|
|
10
|
Demissei BG, Valente MA, Cleland JG,
O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison
B, Givertz MM, et al: Optimizing clinical use of biomarkers in
high-risk acute heart failure patients. Eur J Heart Fail.
18:269–280. 2016. View
Article : Google Scholar
|
|
11
|
Bielecka-Dabrowa A, von Haehling S, Aronow
WS, Ahmed MI, Rysz J and Banach M: Heart failure biomarkers in
patients with dilated cardiomyopathy. Int J Cardiol. 168:2404–2410.
2013. View Article : Google Scholar
|
|
12
|
Patel KP, Zhang K, Zucker IH and Krukoff
TL: Decreased gene expression of neuronal nitric oxide synthase in
hypothalamus and brainstem of rats in heart failure. Brain Res.
734:109–115. 1996. View Article : Google Scholar
|
|
13
|
Li BF, Liu YF, Cheng Y, Zhang KZ, Li TM
and Zhao N: Protective effect of inducible nitric oxide synthase
inhibitor on pancreas transplantation in rats. World J
Gastroenterol. 13:6066–6071. 2007. View Article : Google Scholar :
|
|
14
|
Rajagopalan S, Kurz S, Münzel T, Tarpey M,
Freeman BA, Griendling KK and Harrison DG: Angiotensin II-mediated
hypertension in the rat increases vascular superoxide production
via membrane NADH/NADPH oxidase activation. Contribution to
alterations of vasomotor tone. J Clin Invest. 97:1916–1923. 1996.
View Article : Google Scholar :
|
|
15
|
Jang JH, Chun JN, Godo S, Wu G, Shimokawa
H, Jin CZ, Jeon JH, Kim SJ, Jin ZH and Zhang YH: ROS and
endothelial nitric oxide synthase (eNOS)-dependent trafficking of
angiotensin II type 2 receptor begets neuronal NOS in cardiac
myocytes. Basic Res Cardiol. 110:212015. View Article : Google Scholar :
|
|
16
|
Ratliff BB, Sekulic M, Rodebaugh J and
Solhaug MJ: Angiotensin II regulates NOS expression in afferent
arterioles of the developing porcine kidney. Pediatr Res. 68:29–34.
2010. View Article : Google Scholar :
|
|
17
|
National Research Council (US) Institute
for Laboratory Animal Research, . Guide for the Care and Use of
Laboratory Animals. Washington (DC): National Academies Press (US);
1996
|
|
18
|
Kumar SM Mohan, Kumar PS Mohan and Quadri
SK: Specificity of interleukin-1beta-induced changes in monoamine
concentrations in hypothalamic nuclei: Blockade by interleukin-1
receptor antagonist. Brain Res Bull. 47:29–34. 1998. View Article : Google Scholar
|
|
19
|
Cao H, Wen G and Li H: Role of peroxisome
proliferator-activated receptor α in atherosclerosis. Mol Med Rep.
9:1755–1760. 2014.
|
|
20
|
Campioli E, Batarseh A, Li J and
Papadopoulos V: The endocrine disruptor mono-(2-ethylhexyl)
phthalate affects the differentiation of human liposarcoma cells
(SW 872). PLoS One. 6:e287502011. View Article : Google Scholar :
|
|
21
|
Sousa LE, Magalhães WG, Bezerra FS, Santos
RA, Campagnole-Santos MJ, Isoldi MC and Alzamora AC: Exercise
training restores oxidative stress and nitric oxide synthases in
the rostral ventrolateral medulla of renovascular hypertensive
rats. Free Radic Res. 49:1335–1343. 2015. View Article : Google Scholar
|
|
22
|
Ge JF, Xu YY, Qin G, Peng YN, Zhang CF,
Liu XR, Liang LC, Wang ZZ and Chen FH: Depression-like behavior
induced by Nesfatin-1 in rats: Involvement of increased immune
activation and imbalance of synaptic vesicle proteins. Front
Neurosci. 9:4292015. View Article : Google Scholar :
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ,
Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et
al: Heart disease and stroke statistics-2011 update: A report from
the American Heart Association. Circulation. 123:e18–e29. 2011.
View Article : Google Scholar
|
|
25
|
Watson AM, Hood SG and May CN: Mechanisms
of sympathetic activation in heart failure. Clin Exp Pharmacol
Physiol. 33:1269–1274. 2006. View Article : Google Scholar
|
|
26
|
Floras JS: Sympathetic activation in human
heart failure: dIverse mechanisms, therapeutic opportunities. Acta
Physiol Scand. 177:391–398. 2003. View Article : Google Scholar
|
|
27
|
Gao L, Wang W, Liu D and Zucker IH:
Exercise training normalizes sympathetic outflow by central
antioxidant mechanisms in rabbits with pacing-induced chronic heart
failure. Circulation. 115:3095–3102. 2007. View Article : Google Scholar
|
|
28
|
Aronson D and Burger AJ: Concomitant
beta-blocker therapy is associated with a lower occurrence of
ventricular arrhythmias in patients with decompensated heart
failure. J Card Fail. 8:79–85. 2002. View Article : Google Scholar
|
|
29
|
Kowalewski M, Urban M, Mroczko B and
Szmitkowski M: Proinflammatory cytokines (IL-6, TNF-alpha) and
cardiac troponin I (cTnI) in serum of young people with ventricular
arrhythmias. Pol Arch Med Wewn. 108:647–651. 2002.(In Polish).
|
|
30
|
Kang YM, Yang Q, Yu XJ, Qi J, Zhang Y, Li
HB, Su Q and Zhu GQ: Hypothalamic paraventricular nucleus
activation contributes to neurohumoral excitation in rats with
heart failure. Regen Med Res. 2:22014. View Article : Google Scholar :
|
|
31
|
Ramchandra R and Barrett CJ: Regulation of
the renal sympathetic nerves in heart failure. Front Physiol.
6:2382015. View Article : Google Scholar :
|
|
32
|
Kang YM, Zhang AQ, Zhao XF, Cardinale JP,
Elks C, Cao XM, Zhang ZW and Francis J: Paraventricular nucleus
corticotrophin releasing hormone contributes to sympathoexcitation
via interaction with neurotransmitters in heart failure. Basic Res
Cardiol. 106:473–483. 2011. View Article : Google Scholar :
|
|
33
|
Yildiz M, Hasdemir H, Turkkan C,
Astarcioglu MA, Alper AT, Sahin A and Ozkan M: Acute effects of
cardiac resynchronization therapy on arterial distensibility and
serum norepinephrine levels in advanced heart failure. Cardiol J.
20:304–309. 2013. View Article : Google Scholar
|
|
34
|
Timmermans PB, Duncia JV, Carini DJ, Chiu
AT, Wong PC, Wexler RR and Smith RD: Discovery of losartan, the
first angiotensin II receptor antagonist. J Hum Hypertens. 9 Suppl
5:S3–S18. 1995.
|
|
35
|
Wang Y, Patel KP, Cornish KG, Channon KM
and Zucker IH: nNOS gene transfer to RVLM improves baroreflex
function in rats with chronic heart failure. Am J Physiol Heart
Circ Physiol. 285:H1660–H1667. 2003. View Article : Google Scholar
|
|
36
|
Mann DL: Inflammatory mediators and the
failing heart: Past, present, and the foreseeable future. Circ Res.
91:988–998. 2002. View Article : Google Scholar
|
|
37
|
Anker SD and von Haehling S: Inflammatory
mediators in chronic heart failure: An overview. Heart. 90:464–470.
2004. View Article : Google Scholar :
|
|
38
|
Romano M, Sironi M, Toniatti C,
Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, Van
Hinsbergh V, Sozzani S, et al: Role of IL-6 and its soluble
receptor in induction of chemokines and leukocyte recruitment.
Immunity. 6:315–325. 1997. View Article : Google Scholar
|
|
39
|
Marshall LF: Head injury: Recent past,
present, and future. Neurosurgery. 47:546–561. 2000. View Article : Google Scholar
|
|
40
|
Deten A, Volz HC, Briest W and Zimmer HG:
Cardiac cytokine expression is upregulated in the acute phase after
myocardial infarction. Experimental studies in rats. Cardiovasc
Res. 55:329–340. 2002. View Article : Google Scholar
|
|
41
|
Torre-Amione G, Kapadia S, Benedict C,
Oral H, Young JB and Mann DL: Proinflammatory cytokine levels in
patients with depressed left ventricular ejection fraction: A
report from the studies of left ventricular dysfunction (SOLVD). J
Am Coll Cardiol. 27:1201–1206. 1996. View Article : Google Scholar
|
|
42
|
Helwig BG, Musch T, Craig RA and Kenney
MJ: Increased interleukin-6 receptor expression in the
paraventricular nucleus of rats with heart failure. Am J Physiol
Regul Integr Comp Physiol. 292:R1165–1173. 2007. View Article : Google Scholar
|
|
43
|
Su Q, Liu JJ, Cui W, Shi XL, Guo J, Li HB,
Huo CJ, Miao YW, Zhang M, Yang Q and Kang YM: Alpha lipoic acid
supplementation attenuates reactive oxygen species in hypothalamic
paraventricular nucleus and sympathoexcitation in high salt-induced
hypertension. Toxicol Lett. 241:152–158. 2016. View Article : Google Scholar
|
|
44
|
Stojanović M, Šćepanović L, Hrnčić D,
Rašić-Marković A, Djuric D and Stanojlović O: Multidisciplinary
approach to nitric oxide signaling: Focus on the gastrointestinal
and the central nervous system. Vojnosanitetski Pregled.
72:619–624. 2015. View Article : Google Scholar
|
|
45
|
Cheng WH, Lu PJ, Ho WY, Tung CS, Cheng PW,
Hsiao M and Tseng CJ: Angiotensin II inhibits neuronal nitric oxide
synthase activation through the ERK1/2-RSK signaling pathway to
modulate central control of blood pressure. Circ Res. 106:788–795.
2010. View Article : Google Scholar
|
|
46
|
Capettini LS, Cortes SF, Silva JF,
Alvarez-Leite JI and Lemos VS: Decreased production of neuronal
NOS-derived hydrogen peroxide contributes to endothelial
dysfunction in atherosclerosis. Br J Pharmacol. 164:1738–1748.
2011. View Article : Google Scholar :
|
|
47
|
Liu JL, Murakami H and Zucker IH:
Angiotensin II-nitric oxide interaction on sympathetic outflow in
conscious rabbits. Circ Res. 82:496–502. 1998. View Article : Google Scholar
|
|
48
|
Zhang K, Zucker IH and Patel KP: Altered
number of diaphorase (NOS) positive neurons in the hypothalamus of
rats with heart failure. Brain Res. 786:219–225. 1998. View Article : Google Scholar
|
